PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases.
Juhan ReimandArno de WildeCharlotte E TeunissenMarissa ZwanAlbert D WindhorstRonald BoellaardFrederik BarkhofWiesje M van der FlierPhilip ScheltensBart N M van BerckelRik OssenkoppeleFemke BouwmanPublished in: Alzheimer's research & therapy (2019)
Amyloid status based on either PET or CSF was predicted by different patient features, and this varied by disease stage, suggesting that PET-CSF discordance yields unique information. The stronger associations of both APOE4 carriership and worse memory z-scores with CSF-amyloid in SCD suggest that CSF-amyloid is more sensitive early in the disease course. The higher predictive value of CSF p-tau for a positive PET scan suggests that PET is more specific to AD pathology.